Evidence map›Paper›PMID 39276263›Full record

ArticleEJNMMI physics2024

Quantitative SPECT imaging of

Helena Koniar, Scott McNeil, Luke Wharton, Aidan Ingham, Michiel Van de Voorde, Maarten Ooms, Sathiya Sekar, Cristina Rodríguez-Rodríguez, Peter Kunz, Valery Radchenko and 4 more

Abstract read
In one paragraph

Article in EJNMMI physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. [Pharmaceutics · 2026
    Article
  2. Review
  3. Pre-clinical SPECT and SPECT-CT in Oncology.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  4. Article
  5. First preclinical SPECT/CT imaging and biodistribution of [EJNMMI radiopharmacy and chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Helena KoniarTRIUMF, Life Sciences Division, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada. hkoniar@triumf.ca.ORCID http://orcid.org/0000-0003-0794-9115
Scott McNeilTRIUMF, Life Sciences Division, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada.
Luke WhartonTRIUMF, Life Sciences Division, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada.
Aidan InghamTRIUMF, Life Sciences Division, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada.
Michiel Van de VoordeInstitute for Nuclear Medical Applications Science, SCK CEN, Boeretang 200, Mol, BE, 2400, Canada.
Maarten OomsInstitute for Nuclear Medical Applications Science, SCK CEN, Boeretang 200, Mol, BE, 2400, Canada.
Sathiya SekarFaculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.
Cristina Rodríguez-RodríguezDepartment of Physics and Astronomy, University of British Columbia, 6224 Agricultural Road, Vancouver, BC, CAN V6T, Canada.
Peter KunzTRIUMF, Accelerator Division, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada.
Valery RadchenkoTRIUMF, Life Sciences Division, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada.
Arman RahmimDepartment of Physics and Astronomy, University of British Columbia, 6224 Agricultural Road, Vancouver, BC, CAN V6T, Canada.
Carlos UribeDepartment of Radiology, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
Hua YangTRIUMF, Life Sciences Division, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada.
Paul SchafferTRIUMF, Life Sciences Division, 4004 Wesbrook Mall, Vancouver, BC, V6T 2A3, Canada.

Funding

Canada Foundation for Innovation 25413Government of Canada's New Frontiers in Research Fund-Exploration NFRFE-2019-00128National Research Council of Canada National Research Council of CanadaNational Science and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2018-04997National Science and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2021-04093National Science and Engineering Research Council of Canada (NSERC) Discovery Grant RGPIN-2022-03887National Science and Engineering Research Council of Canada (NSERC) Discovery Grant SAPIN2021-00030
6 · The paper itself

Abstract

backgroundElement-equivalent matched theranostic pairs facilitate quantitative in vivo imaging to establish pharmacokinetics and dosimetry estimates in the development of preclinical radiopharmaceuticals. Terbium radionuclides have significant potential as matched theranostic pairs for multipurpose applications in nuclear medicine. In particular,

resultsQuantitative SPECT images of the resolution phantom established that the HEUHR collimator resolved all rods for

conclusionsBoth

Indexed as

Preclinical imagingQuantitative SPECTRadiopharmaceutical therapyTerbium-155Terbium-161Theranostic pair

Identifiers

PMID39276263
PMCPMC11401819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.